Hostname: page-component-cd9895bd7-8ctnn Total loading time: 0 Render date: 2024-12-24T00:18:21.305Z Has data issue: false hasContentIssue false
  • English
  • Français

Iloprost-induced sudden hearing loss

Published online by Cambridge University Press:  15 March 2007

E Dursun ,
S Dogru ,
H Cincik ,
E Cekin ,
A Gungor  and
E Poyrazoglu
E Dursun
Affiliation:
Department of Otorhinolaryngology, GATA Haydarpasa Training Hospital, Istanbul, Turkey.
S Dogru
Affiliation:
Department of Otorhinolaryngology, GATA Haydarpasa Training Hospital, Istanbul, Turkey.
H Cincik
Affiliation:
Department of Otorhinolaryngology, GATA Haydarpasa Training Hospital, Istanbul, Turkey.
E Cekin
Affiliation:
Department of Otorhinolaryngology, GATA Haydarpasa Training Hospital, Istanbul, Turkey.
A Gungor
Affiliation:
Department of Otorhinolaryngology, GATA Haydarpasa Training Hospital, Istanbul, Turkey.
E Poyrazoglu
Affiliation:
Department of Otorhinolaryngology, GATA Haydarpasa Training Hospital, Istanbul, Turkey.
Get access Rights & Permissions [Opens in a new window]

Abstract

We report a patient who developed sudden, bilateral, sensorineural hearing loss during therapeutic use of iloprost for Raynaud's phenomenon. The sudden hearing loss was attributed to iloprost use and completely reversed in eight days with conservative therapy. Iloprost may be a potentially ototoxic drug, causing sudden hearing loss.

Keywords

IloprostProstacyclinSensorineural DeafnessDrug Toxicity
Type
Clinical Records
Information
The Journal of Laryngology & Otology , Volume 121 , Issue 6 , June 2007 , pp. 609 - 610
Copyright
2007 JLO (1984) Limited

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)